CRIS Current Research Information System

MACCHINI, MARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.645
EU - Europa 2.234
AS - Asia 2.191
AF - Africa 207
SA - Sud America 164
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.445
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.621
CN - Cina 681
SG - Singapore 679
GB - Regno Unito 483
IT - Italia 456
VN - Vietnam 426
SE - Svezia 287
DE - Germania 249
HK - Hong Kong 148
IN - India 121
RU - Federazione Russa 119
BR - Brasile 118
CH - Svizzera 108
UA - Ucraina 106
IE - Irlanda 91
FR - Francia 83
NL - Olanda 70
ZA - Sudafrica 50
KR - Corea 49
CI - Costa d'Avorio 44
TG - Togo 41
NG - Nigeria 37
FI - Finlandia 36
EE - Estonia 35
AT - Austria 30
JP - Giappone 26
BG - Bulgaria 21
SC - Seychelles 21
AR - Argentina 17
BE - Belgio 17
JO - Giordania 15
ID - Indonesia 13
CA - Canada 12
PL - Polonia 12
IR - Iran 8
MX - Messico 8
ES - Italia 7
CL - Cile 6
EC - Ecuador 6
HR - Croazia 5
TR - Turchia 5
BD - Bangladesh 4
CO - Colombia 4
LT - Lituania 4
NI - Nicaragua 4
PY - Paraguay 4
GR - Grecia 3
PE - Perù 3
PT - Portogallo 3
UY - Uruguay 3
AU - Australia 2
BY - Bielorussia 2
CM - Camerun 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
LB - Libano 2
NP - Nepal 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TW - Taiwan 2
UZ - Uzbekistan 2
VE - Venezuela 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BO - Bolivia 1
BW - Botswana 1
IL - Israele 1
IQ - Iraq 1
KH - Cambogia 1
KZ - Kazakistan 1
MA - Marocco 1
ML - Mali 1
MR - Mauritania 1
MU - Mauritius 1
MY - Malesia 1
NZ - Nuova Zelanda 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
TN - Tunisia 1
XK - ???statistics.table.value.countryCode.XK??? 1
YT - Mayotte 1
Totale 7.445
Salva come PNG Salva come JPEG
Città #
Southend 437
Singapore 425
Ashburn 320
Chandler 237
Fairfield 208
Dong Ket 204
Santa Clara 150
Hong Kong 147
Princeton 118
Houston 108
Bern 105
Wilmington 101
Beijing 95
Hefei 93
New York 92
Ann Arbor 91
Dublin 91
Woodbridge 80
Seattle 71
Dallas 63
Boardman 60
Cambridge 57
Jacksonville 56
Nanjing 49
Seoul 49
Bologna 48
Westminster 47
Padova 45
Abidjan 44
Los Angeles 43
Lomé 41
Ho Chi Minh City 35
Medford 35
Rome 34
Turin 34
Abeokuta 32
Helsinki 32
Berlin 30
Milan 30
Shenyang 29
Hanoi 27
Jinan 26
Tokyo 25
Saint Petersburg 24
Florence 22
Redondo Beach 22
Sofia 21
Buffalo 20
Mülheim 20
Dearborn 19
Hebei 19
Changsha 17
Guangzhou 16
Amman 15
Tianjin 15
Frankfurt am Main 14
Nanchang 14
Brussels 13
Fremont 13
Kyiv 13
Munich 13
Redwood City 13
Vienna 13
San Diego 12
Taiyuan 12
Falls Church 11
Jiaxing 11
Nuremberg 11
Des Moines 10
Ravenna 10
Shanghai 10
São Paulo 10
Xi'an 10
Bengaluru 9
San Venanzo 9
Warsaw 9
Yubileyny 9
Zhengzhou 9
Hangzhou 8
Brooklyn 7
Falkenstein 7
Haikou 7
Jakarta 7
Kunming 7
Olalla 7
Düsseldorf 6
Forlì 6
Haiphong 6
Mahé 6
Mumbai 6
Norwalk 6
Phoenix 6
Tongling 6
Torino 6
Toronto 6
Atlanta 5
Bari 5
Chicago 5
Monmouth Junction 5
Ningbo 5
Totale 4.767
Salva come PNG Salva come JPEG
Nome #
Follow-up del cancro del pancreas esocrino 402
Characterization of pancreatic ductal adenocarcinoma using whole transcriptome sequencing and copy number analysis by single-nucleotide polymorphism array 230
Antiprotease strategy in combination with gemcitabine as a putative novel therapeutic approach for pancreatic cancer treatment 216
Characterization of pancreatic ductal adenocarcinoma patients using whole-transcriptome sequencing and copy number analysis by SNPs array techniques. 214
Antiprotease strategy in pancreatic cancer treatment: emergence from a preclinical study. 210
Comparing recist and Choi’s criteria to evaluate radiological response to chemotherapy in patients with advanced pancreatic cancer 196
Chemotherapy followed by chemoradiotherapy in locally advanced pancreatic cancer:A literature review and report of two cases 193
β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer 184
Venous thromboembolism and port-related thrombosis in metastatic colorectal cancer patients: a monocenter experience. 179
Clinical impact of nonselective beta-blockers on survival in patients with pancreatic cancer- revival of well known drugs? 164
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: An interim report of a prospective randomized study 161
GemOx and Ovarian Pancreatic Cancer Metastasis (PC) 159
Comparing RECIST and Choi's Criteria After Neoadjuvant Chemoradiotherapy in Patients with Resectable Pancreatic Cancer 159
State of the art biological therapies in pancreatic cancer 157
Advanced pancreatic cancer (APC) A monocenter experience in 53 patients: is it possible a second line treatment? 152
Retroperitoneal lymphangioma: A report of 2 cases and a review of the literature regarding the differential diagnoses of retroperitoneal cystic masses 146
CIRCULATING METALLOPROTEINASE-3 AND TISSUE INHIBITOR OF METALLOPROTEINASE-2 IN PATIENTS WITH DUCTAL PANCREATIC NEOPLASMS 137
Preoperatory Gemcitabine and Oxaliplatin in a patient with ovarian metastasis from pancreatic cystadenocarcinoma 134
Metastatic pancreatic cancer: is gemcitabine still the best standard treatment? 133
Hedgehog Signaling: from the Cuirass to the Heart of Pancreatic Cancer 131
Gemox in combination witherlotinib (E) in pancreatic cancer (PC). 131
Advanced pancreatic cancer (apc); a Monocenter experience in 53 patients. It is possible a second line treatment? 130
Role of adjuvant chemoradiotherapy (CRT) and chemotherapy alone in pancreatic cancer: experience in 25 patients. 127
The Protease Inhibitor Gabexate Mesylate Reduces Invasiveness and Angiogenesis in Pancreatic Cancer Cell Lines, Enhancing Gemcitabine Action 125
Prognostic factors for recurrence in resected pancreatic adenocarcinoma: a single center experience 124
Long-Term Survival After Pancreaticoduodenectomy for Pancreatic Ductal Adenocarcinoma. Case Report 123
Useful of Choi’s criteria after neoadjuvant chemoradiotherapy in patients with resectable pancreatic cancer. 123
GEMOX AS FIRST-LINE CHEMOTHERAPY IN ADVANCED PANCREATIC CANCER (APC): A MONOINSTITUTIONAL EXPERIENCE 122
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 122
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Advanced Pancreatic Cancer 121
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 119
Erratum: β2 Adrenergic-Neurotrophin Feedforward Loop Promotes Pancreatic Cancer (Cancer Cell (2018) 33(1) (75–90.e7), (S153561081730510X) (10.1016/j.ccell.2017.11.007)) 119
Prognostic factors in resected pancreatic cancer:a single centre experience 117
The follow-up issues: from the necessity to the opportunity 117
Germinal BRCA1-2 pathogenic variants (gBRCA1-2pv) and pancreatic cancer: epidemiology of an Italian patient cohort 116
Locally Advanced Pancreatic Cancer: Is It Possible Pancreatic Resection? A Case Report 116
Whole Transcriptome Sequencing Reveals Molecular Prognostic Markers in Pancreatic Adenocarcinoma 116
Neoadjuvant Therapy for Resectable Pancreatic Adenocarcinoma: An Interim Report of a Prospective Controlled Randomized Study 116
Real-World Impact of Olaparib Exposure in Advanced Pancreatic Cancer Patients Harboring Germline BRCA1-2 Pathogenic Variants 114
Whole-transcriptome paired-end sequencing and the pancreatic cancer genetic landscape 113
Comparing RECIST and Choi’s Criteria to Evaluate Radiological Response to Chemotherapy in Patients with Resectable and Advanced Pancreatic Cancer. 112
Chemotherapy toxicity and activity in patients with pancreatic ductal adenocarcinoma and germline BRCA1-2 pathogenic variants (gBRCA1-2pv): a multicenter survey 111
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma. 109
Survival analysis of the non-metastatic cohort of the Italian Association for Medical Oncology (AIOM) Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy (GARIBALDI) 108
Neoadjuvant therapy for resectable pancreatic adenocarcinoma: an interim report of a prospective controlled randomized study. 101
Whole Transcriptome Sequencing Reveals Somatic HMGCR Mutation in a Case of Pancreatic Adenocarcinoma with Long-Term Therapy Response 100
New WHO classification for pancreatic endocrine tumours: is time to leave the previous one 99
Whole genome discovery of genetic alterations carried by pancreatic adenocarcinoma 97
SNP-Array High Resolution Cytogenetic Analysis of Resectable and Advanced Pancreatic Cancer 91
Whole genome discovery of genetic alterations in resectable and advanced pancreatic cancer. 91
Resection Margin Involvement in Pancreaticoduodenectomy. A Single Centre Experience 91
Role of CA 19-9 Concentration as an Independent Prognostic Factor in Unresectable Pancreatic Ductal Adenocarcinoma (PDCA) Treated with GemOx 87
Second-line therapy in pancreatic ductal adenocarcinoma (PDAC) patients with germline BRCA1-2 pathogenic variants (gBRCA1-2pv) 85
Massively Parallel Sequencing Analysis of Genetic Alterations Carried by Pancreatic Adenocarcinoma 84
Guideline Application in Real world: multi-Institutional Based survey of Adjuvant and first-Line pancreatic Ductal adenocarcinoma treatment in Italy. Primary analysis of the GARIBALDI survey 63
Survival analysis of the metastatic cohort of Italian Association of Medical Oncology (AIOM) GARIBALDI survey 58
1517P Isolated LUng Metastases in pancreatic AdenoCArcinoma patients in a multicenter Italian cohort: The LU.M.A.CA study 53
Preoperative mFOLFIRINOX versus PAXG for stage I–III resectable and borderline resectable pancreatic ductal adenocarcinoma (PACT-21 CASSANDRA): results of the first randomisation analysis of a randomised, open-label, 2 × 2 factorial phase 3 trial 10
Totale 7.618
Salva come PNG Salva come JPEG
Categoria #
all - tutte 19.781
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.781
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021587 0 0 0 0 0 35 15 44 69 30 32 362
2021/2022994 80 44 30 70 89 51 13 57 38 107 240 175
2022/20231.238 105 173 69 133 80 102 13 84 169 51 135 124
2023/2024405 26 44 10 37 34 135 17 31 9 21 23 18
2024/20251.251 59 136 98 66 232 56 112 87 25 95 47 238
2025/20261.542 278 282 273 232 323 154 0 0 0 0 0 0
Totale 7.618